Rapt Therapeutics, Inc. (RAPT)
57.82
+0.10
(+0.17%)
USD |
NASDAQ |
Feb 12, 16:00
57.82
0.00 (0.00%)
After-Hours: 20:00
Rapt Therapeutics Cash from Investing (Quarterly) : 8.466M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Penumbra, Inc. | -162.86M |
| Boston Scientific Corp. | -- |
| Johnson & Johnson | -4.485B |
| Merck & Co., Inc. | -- |
| Pfizer Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.46M |
| Cash from Financing (Quarterly) | 0.036M |
| Free Cash Flow | -86.66M |
| Free Cash Flow Per Share (Quarterly) | -0.462 |
| Free Cash Flow to Equity (Quarterly) | -11.89M |
| Free Cash Flow to Firm (Quarterly) | -12.46M |
| Free Cash Flow Yield | -1.90% |